Efficacy and safety of triple therapy with aprepitant, ondansetron, and prednisone for preventing nausea and vomiting induced by R-CEOP or CEOP chemotherapy regimen for non-Hodgkin lymphoma: a phase 2 open-label, randomized comparative trial

  • Zheng Song, Huaqing Wang, Huilai Zhang, Kuo Zhao, Man Zhang, Fang Yang
  • Leukemia & Lymphoma, August 2016, Taylor & Francis
  • DOI: 10.1080/10428194.2016.1213838

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/10428194.2016.1213838